Search Results - "LaMoreaux, Brian D"

Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk by Feaver, Ryan E, Bowers, M. Scott, Cole, Banumathi K, Hoang, Steve, Lawson, Mark J, Taylor, Justin, LaMoreaux, Brian D, Zhao, Lin, Henke, Brad R, Johns, Brian A, Nyborg, Andrew C, Wamhoff, Brian R, Figler, Robert A

“…Some health concerns are often not identified until late into clinical development of drugs, which can place participants and patients at significant risk. For…”
Get full text

New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation by Li, Justin W., Yin, David, Wang, Zheng, Brigham, Mark D., LaMoreaux, Brian D., Kent, Jeffrey D., Francis-Sedlak, Megan, Johnson, Richard J., Hadker, Nandini, Francis, Kevin M., Sanchez, Herman A., Miyasato, Gavin

“…The causal relationship between gout and renal transplant outcomes is difficult to assess due to multiple interacting covariates. This study sought to estimate…”
Get full text

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis by Lovell, Daniel J, Dare, Jason A, Francis-Sedlak, Megan, Ball, Julie, LaMoreaux, Brian D, Von Scheven, Emily, Reinhardt, Adam, Jerath, Rita, Alpan, Oral, Gupta, Ramesh, Goldsmith, Donald, Zeft, Andrew, Naddaf, Henry, Gottlieb, Beth, Jung, Lawrence, Holt, Robert J

“…Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age…”
Get full text

Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist by LaMoreaux, Brian, MD, Barbar-Smiley, Fatima, MD, Ardoin, Stacy, MD, Madhoun, Hareth, DO

“…Abstract Introduction Romiplostim is a thrombopeitin-receptor agonist approved for raising platelet counts in patients with immune thrombocytopenia (ITP)…”
Get full text